Spineway

PA:ALSPW France Medical Instruments & Supplies
Market Cap
$5.73 Million
€5.58 Million EUR
Market Cap Rank
#30214 Global
#315 in France
Share Price
€0.16
Change (1 day)
+3.15%
52-Week Range
€0.10 - €0.23
All Time High
€1000000.00
About

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The comp… Read more

Spineway (ALSPW) - Total Assets

Latest total assets as of June 2025: €30.20 Million EUR

Based on the latest financial reports, Spineway (ALSPW) holds total assets worth €30.20 Million EUR as of June 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Spineway - Total Assets Trend (2009–2024)

This chart illustrates how Spineway’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Spineway - Asset Composition Analysis

Current Asset Composition (December 2024)

Spineway's total assets of €30.20 Million consist of 45.7% current assets and 54.3% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 14.9%
Accounts Receivable €3.30 Million 10.9%
Inventory €4.73 Million 15.6%
Property, Plant & Equipment €2.53 Million 8.3%
Intangible Assets €3.61 Million 11.9%
Goodwill €5.90 Million 19.4%

Asset Composition Trend (2009–2024)

This chart illustrates how Spineway's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Spineway's current assets represent 45.7% of total assets in 2024, an increase from 0.0% in 2009.
  • Cash Position: Cash and equivalents constituted 14.9% of total assets in 2024, up from 1.4% in 2009.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 0.0% in 2009.
  • Asset Diversification: The largest asset category is goodwill at 19.4% of total assets.

Spineway Competitors by Total Assets

Key competitors of Spineway based on total assets are shown below.

Company Country Total Assets
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
China CN¥3.82 Billion
Blue Sail Medical Co Ltd
SHE:002382
China CN¥16.46 Billion
Andon Health Co Ltd
SHE:002432
China CN¥28.98 Billion
Allmed Medical Products Co Ltd Class A
SHE:002950
China CN¥5.35 Billion
Inix Technologies Holdings Bhd
KLSE:0094
Malaysia RM72.53 Million
Focus Point Holdings Bhd
KLSE:0157
Malaysia RM328.19 Million
Careplus Group Bhd
KLSE:0163
Malaysia RM286.61 Million
LKL International Bhd
KLSE:0182
Malaysia RM173.46 Million

Spineway - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.17 - 0.97

Lower asset utilization - Spineway generates 0.39x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -95.26% - -6.19%

Negative ROA - Spineway is currently not profitable relative to its asset base.

Spineway - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.34 2.34 1.29
Quick Ratio 1.50 1.29 0.82
Cash Ratio 0.00 0.00 0.00
Working Capital €7.68 Million € 6.83 Million € 1.46 Million

Spineway - Advanced Valuation Insights

This section examines the relationship between Spineway's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.27
Latest Market Cap to Assets Ratio 0.22
Asset Growth Rate (YoY) 15.6%
Total Assets €30.41 Million
Market Capitalization $6.68 Million USD

Valuation Analysis

Below Book Valuation: The market values Spineway's assets below their book value (0.22 x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Spineway's assets grew by 15.6% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Spineway (2009–2024)

The table below shows the annual total assets of Spineway from 2009 to 2024.

Year Total Assets Change
2024-12-31 €30.41 Million +15.57%
2023-12-31 €26.31 Million -5.00%
2022-12-31 €27.70 Million +8.32%
2021-12-31 €25.57 Million +73.37%
2020-12-31 €14.75 Million +15.45%
2019-12-31 €12.77 Million +71.90%
2018-12-31 €7.43 Million -25.03%
2017-12-31 €9.91 Million +4.89%
2016-12-31 €9.45 Million +5.45%
2015-12-31 €8.96 Million -20.27%
2014-12-31 €11.24 Million +20.80%
2013-12-31 €9.31 Million +89.55%
2012-12-31 €4.91 Million +31.09%
2011-12-31 €3.74 Million +50.15%
2010-12-31 €2.49 Million +21.13%
2009-12-31 €2.06 Million --